Ghana has taken a historic step in developing its medicinal and industrial cannabis sector after the Narcotics Control Commission (NACOC) officially granted the country's first cultivation licences to MJ Adom Limited and Juliopta Limited.
The licences, presented during a ceremony in Accra, authorise the two companies to cultivate cannabis strictly for medicinal, industrial, and scientific research purposes under Ghana's regulatory framework. The development follows months of preparations by NACOC after the introduction of a national licensing regime earlier this year.
Speaking at the presentation ceremony, NACOC Director-General Major General Maxwell Obuba Mantey described the milestone as the beginning of a carefully regulated industry that has the potential to generate employment, attract foreign investment, and promote scientific research in Ghana.
He stressed that the licensing process was rigorous, involving detailed technical assessments, field inspections, and reviews by a multi-agency committee before approval was granted by the Minister for the Interior. According to him, only applicants who met all legal, financial, technical, and security requirements qualified for the licences.
Major General Mantey cautioned that the licences apply only to cannabis containing no more than 0.3 percent tetrahydrocannabinol (THC), the psychoactive component of the plant. He emphasised that recreational cannabis remains illegal in Ghana and warned that anyone cultivating cannabis without authorisation or exceeding the approved THC limit would face prosecution under the law.
He further revealed that NACOC officers will conduct routine inspections, both announced and unannounced, to ensure strict compliance with the licence conditions. Companies found violating the regulations risk having their licences revoked and could face criminal sanctions.
Representatives of the two licensed companies welcomed the development, describing it as the beginning of a new chapter for Ghana's agricultural and pharmaceutical sectors. Officials from Juliopta Limited said they intend to develop products for both local and international markets, while MJ Adom Limited indicated it would collaborate with research institutions, including the Centre for Plant Medicine Research, to explore the medicinal benefits of cannabis.
Industry experts believe the regulated cultivation of medicinal cannabis could create new employment opportunities, diversify agricultural exports, and attract investment into pharmaceutical manufacturing. However, they also stress that strict regulation will be essential to prevent abuse and maintain public confidence in the new industry.
The licences are valid for three years, subject to continuous compliance with Ghana's cannabis regulations and periodic inspections by NACOC. Authorities have indicated that more licences could be issued in the future as additional companies satisfy the Commission's stringent requirements.
The issuance of Ghana's first medicinal cannabis cultivation licences represents a landmark moment in the country's agricultural and healthcare sectors. While the initiative is expected to open new economic opportunities, NACOC has made it clear that the industry will operate under strict supervision to ensure cannabis is cultivated solely for approved medicinal, industrial, and research purposes. As Ghana enters this new chapter, the success of the programme will depend on strong regulation, responsible investment, and continued compliance with the law.